AC IMMUNE SA
ACIU · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $2.44
- Today’s Low
- $2.39
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.50
- Previous Close
- $2.45
- Volume
- 148.47K
- Market Cap
- $249.34M
- P/E Ratio
- --
- EPS
- $-0.43
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- BUILDING B, LAUSANNE, SWITZERLAND, 1015
- Country
- CH
- Listing Date
- 2016-09-23
- Fiscal Year End
- December
- Shares Outstanding
- 101.77M
- CIK
- 0001651625
- Website
- www.acimmune.com
AC Immune SA, a clinical-stage biopharmaceutical company, discovers, designs and develops drugs and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company is headquartered in Lausanne, Switzerland.
Financial Metrics
Revenue
2026-06-30
$15.11M
2026-03-31
$1.11M
2025-12-31
$338K
2025-09-30
$939K
Operating Expenses
2026-06-30
$13.92M
2026-03-31
$15.9M
2025-12-31
$14.74M
2025-09-30
$17.1M
Net Income
2026-06-30
$1.87M
2026-03-31
-$14.8M
2025-12-31
-$14.37M
2025-09-30
-$15.85M
Net Profit Margin
2026-06-30
12.39%
2026-03-31
-1.32K%
2025-12-31
-4.25K%
2025-09-30
-1.68K%
Earnings Per Share
2026-06-30
$0.03
2026-03-31
$-0.15
2025-12-31
$-0.14
2025-09-30
$-0.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$1.93M
2026-03-31
-$14.73M
2025-12-31
-$13.67M
2025-09-30
-$15.24M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $15.11M | $1.11M | $338K | $939K |
| Operating Expenses | $13.92M | $15.9M | $14.74M | $17.1M |
| Net Income | $1.87M | -$14.8M | -$14.37M | -$15.85M |
| Net Profit Margin | 12.39% | -1.32K% | -4.25K% | -1.68K% |
| Earnings Per Share | $0.03 | $-0.15 | $-0.14 | $-0.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $1.93M | -$14.73M | -$13.67M | -$15.24M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.